Frazier Life Sciences
vc
Frazier Life Sciences is a venture capital firm specializing in early-stage biotechnology investments, with a specific focus on small and mid-size public biotechs. The firm recently closed an oversubscribed $1.3 billion fund dedicated to these early-stage opportunities, building on its history of managing significant capital in the life sciences sector. While headquartered in the United States, it operates as a global investor within the broader LATAM and international venture ecosystem.